(4S,5S)-(-)-4-甲氧甲基-2-甲基-5-苯基-2-恶唑啉
| 英文名 | (4S,5S)-4-(Methoxymethyl)-2-methyl-5-phenyl-4,5-dihydrooxazole | CAS号 | 52075-14-6 |
| 试剂别名 |
Oxazole,4,5-dihydro-4-(methoxymethyl)-2-methyl-5-phenyl-, (4S,5S)-;(4S,5S)-(-)-4-Methoxymethyl-2-methyl-5-phenyl-2-oxazoline;(4S,5S)-(-)-4,5-Dihydro-4-methoxymethyl-2-methyl-5-phenyloxazole;(-)-(4S,5S)-4-(Methoxymethyl)-2-methyl-5-phenyl-2-oxazolin;(-)-(4S,5S)-4-(methoxymethyl)-2-methyl-5-phenyl-2-oxazoline;(4S,5S)-(-)-4,5-DIHYDRO-4-METHOXYMETHYL-2-ME-5-PHENYLOXAZOL;(4S,5S)-(-)-4,5-DIHYDRO-4-METHOXYMETHYL-2-METHYL-5-PHENYLOXAZOL;(4S,5S)-()-4,5-Dihydro-4-methoxymethyl-2-methyl-5-phenyloxazole,(4S,;trans-(4S,5S)-(+)-2-methyl-4-methoxymethyl-5-phenyl-2-oxazoline;Meyer's oxazoline
|
分子式 | C12H15NO2 |
| 产品编号 | M0803 | 分子量 | 205.25 |
| MDL号 |
| 产品名称： | (4S,5S)-(-)-4-甲氧甲基-2-甲基-5-苯基-2-恶唑啉 |
| 英文名称： | (4S,5S)-4-(Methoxymethyl)-2-methyl-5-phenyl-4,5-dihydrooxazole |
| 英文别名： | Oxazole,4,5-dihydro-4-(methoxymethyl)-2-methyl-5-phenyl-, (4S,5S)-;(4S,5S)-(-)-4-Methoxymethyl-2-methyl-5-phenyl-2-oxazoline;(4S,5S)-(-)-4,5-Dihydro-4-methoxymethyl-2-methyl-5-phenyloxazole;(-)-(4S,5S)-4-(Methoxymethyl)-2-methyl-5-phenyl-2-oxazolin;(-)-(4S,5S)-4-(methoxymethyl)-2-methyl-5-phenyl-2-oxazoline;(4S,5S)-(-)-4,5-DIHYDRO-4-METHOXYMETHYL-2-ME-5-PHENYLOXAZOL;(4S,5S)-(-)-4,5-DIHYDRO-4-METHOXYMETHYL-2-METHYL-5-PHENYLOXAZOL;(4S,5S)-()-4,5-Dihydro-4-methoxymethyl-2-methyl-5-phenyloxazole,(4S,;trans-(4S,5S)-(+)-2-methyl-4-methoxymethyl-5-phenyl-2-oxazoline;Meyer's oxazoline |
| 中文别名： | (4S,5S)-(-)-4-甲氧甲基-2-甲基-5-苯基-2-噁唑啉;(4S,5S)-(-)-4-甲氧甲基-2-甲基-5-苯基-2-恶唑啉;(4S,5S)-(-)-4,5-二氢-4-甲氧基甲基-2-甲基-5-苯基噁唑;(4S,5S)-(-)-4-Methoxymethyl-2-methyl-5-phenyl-2-oxazoline (4S,5S)-(-)-4-甲氧甲基-2-甲基-5-苯基-2-恶唑啉;(4S,5s)-(-)-4-甲氧基甲基-2-甲基-5-苯基-2-噁唑啉;(4S,5S)-(-)-4-甲氧基甲基-2-甲基-5-苯基-2-唑啉;(4S,5S)-4-甲氧基甲基-2-甲基-5-苯基-2-恶唑啉;(4S,5S)-4-甲氧甲基-2-甲基-5-苯基-2-噁唑啉 (4S,5S)-(-)-4-甲氧基甲基-2-甲基-5-苯基-2-唑啉 |
| CAS No.： | 52075-14-6 |
| 分子式： | C12H15NO2 |
| 分子量： | 205.25 |
| 危险品级别： | |
| HS符号： | |
| 危害声明： |
